View Daily Data Tracking History
View Bill Text
View Statement of Purpose / Fiscal Impact
H0707.................................................by HEALTH AND WELFARE
PHARMACY - Amends existing law to establish pharmacy reimbursement rates
through June 30, 1998, and to permit negotiated rulemaking to establish
rates thereafter.
02/13 House intro - 1st rdg - to printing
02/16 Rpt prt - to Health/Wel
03/05 Rpt out - rec d/p - to 2nd rdg
03/06 2nd rdg - to 3rd rdg
03/09 3rd rdg - PASSED - 66-1-3
AYES -- Alltus, Barraclough, Barrett, Bell, Bieter, Bivens,
Black(15), Black(23), Boe, Bruneel, Callister, Campbell, Chase,
Clark, Crane, Crow, Cuddy, Deal, Denney, Ellsworth, Gagner, Geddes,
Gould, Hadley, Hansen, Henbest, Hornbeck, Jaquet, Jones(9),
Jones(22), Judd, Kellogg, Kempton, Kendell, Kjellander, Kunz, Lake,
Linford, Loertscher, Mader, Marley, McKague, Meyer, Miller,
Mortensen, Newcomb, Pischner, Pomeroy, Reynolds, Richman, Ridinger,
Robison, Sali, Schaefer, Stevenson, Stone, Stubbs, Taylor, Tilman,
Tippets, Trail, Watson, Wheeler, Wood, Zimmermann, Mr Speaker
NAYS -- Stoicheff
Absent and excused -- Field(13), Field(20), Jones(20),
Floor Sponsor - Jaquet
Title apvd - to Senate
03/10 Senate intro - 1st rdg - to Health/Wel
03/13 Rpt out - rec d/p - to 2nd rdg
03/16 2nd rdg - to 3rd rdg
03/18 3rd rdg - PASSED - 34-0-1
AYES--Andreason, Boatright, Branch, Bunderson, Burtenshaw, Cameron,
Crow, Danielson, Darrington, Deide, Dunklin, Frasure, Geddes,
Hawkins, Ingram, Ipsen, Keough, King, Lee, McLaughlin, Noh, Parry,
Richardson, Riggs, Risch, Sandy, Schroeder, Sorensen, Stennett,
Sweeney, Thorne, Twiggs, Wheeler, Whitworth
NAYS--None
Absent and excused--Hansen
Floor Sponsor - Wheeler
Title apvd - to House
03/19 To enrol - rpt enrol - Sp signed
Pres signed - to Governor
03/20 Governor signed
Session Law Chapter 187
Effective: 07/01/98
H0707|||| LEGISLATURE OF THE STATE OF IDAHO |||| Fifty-fourth Legislature Second Regular Session - 1998IN THE HOUSE OF REPRESENTATIVES HOUSE BILL NO. 707 BY HEALTH AND WELFARE COMMITTEE 1 AN ACT 2 RELATING TO PHARMACY REIMBURSEMENT; AMENDING SECTION 56-209g, IDAHO CODE, TO 3 ESTABLISH PHARMACY REIMBURSEMENT RATES AND TO AUTHORIZE ADJUSTMENT OF 4 RATES THROUGH NEGOTIATED RULEMAKING. 5 Be It Enacted by the Legislature of the State of Idaho: 6 SECTION 1. That Section 56-209g, Idaho Code, be, and the same is hereby 7 amended to read as follows: 8 56-209g. PHARMACY REIMBURSEMENT.From January 1, 1991, through9December 31, 1994, pursuant to federal action, a moratorium on reduction of10pharmacy reimbursement levels for medicaid under title XIX of the social secu-11rity act has been in effectMedicaid pharmacy reimbursement lev- 12 els are a combination of the cost of the drug and a dispensing fee which 13 includes such pharmaceutical care services as counseling, obtaining a patient 14 history, documentation, and dispensing . From and after January 1, 1995, 15 through June 30, 1998, it shall be the policy of the state of 16 Idaho that there be no reduction of pharmacy reimbursement levels for medicaid 17 under title XIX of the social security act except as necessary to comply with 18 federal regulations, 42 CFR 447.331 through 447.334, as implemented in the 19 state of Idaho. Effective July 1, 1998, pharmacy reimbursement levels 20 may be adjusted in accordance with rules promulgated by the director through 21 negotiated rulemaking with interested parties including representatives of the 22 pharmacy profession.
STATEMENT OF PURPOSE
RS07941
Consistent with the Governor's Medicaid Reform initiatives, the purpose of this legislation
is to give the state flexibility to adjust, through negotiated rule-making with interested
parties including representatives of the pharmacy profession, reimbursement for
prescription drugs purchased in connection with the state's medical assistance program.
Current state law prohibits the department from reducing payment levels except where
federal upper payment limits are exceeded. This legislation will allow the department the
flexibility to consider both components of the reimbursement level, the dispensing fee and
the cost of the drug, in determining appropriate payment levels.
FISCAL IMPACT
While no cost to the state is anticipated, any savings is dependent on the rules that are
negotiated.
CONTACT
Name: Kathleen Allyn
Agency:Department of Health and Welfare
Phone: 334-5747
Statement of Purpose/Fiscal Impact
H 707